HighTower Advisors’s Opus Genetics IRD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRD
AIC
HighTower Advisors's IRD Position: Q3 2026 in Review
HighTower Advisors opened a new position in Opus Genetics (IRD) in Q3 2026: 20,500 shares worth $99.2K. The stake represents ﹤0.01% of the portfolio and ranks #3684 among its holdings.
78 funds tracked by Wall St. Rank hold IRD as of Q3 2026.
- HighTower Advisors held 20,500 shares of Opus Genetics worth $99.2K as of Q3 2026.
- Opus Genetics was a new HighTower Advisors position in Q3 2026.
- Opus Genetics made up ﹤0.01% of HighTower Advisors's portfolio in Q3 2026, its #3684 holding.
- 78 funds tracked by Wall St. Rank held Opus Genetics as of Q3 2026.
Based on HighTower Advisors's 13F filing for Q3 2026, filed 10 Nov 2026.